Top Markets
#1 Siren Siren +34.84%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.77%
#3 Ribbita by Virtuals Ribbita by Virtuals +20.39%
#4 Wiki Cat Wiki Cat +18.83%
#5 Cysic Cysic +17.67%
#6 PulseChain PulseChain +17.12%
#7 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.51%
#8 Velvet Velvet +16.46%
#9 The Grays Currency The Grays Currency +16.46%
#10 KUB Coin KUB Coin +16.41%
Coin of the day
Siren Siren
Setări
Limbă
ROMâNă
Monedă
USD
Temă
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rang în acțiuni #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Preț acțiune
$0.404
Capitalizare de piață
$14.28M
Schimbare (1 zi)
-10.42%
Schimbare (1 an)
-67.68%
Țară
IL
Tranzacționează NeuroSense Therapeutics Ltd. (NRSN)

Categorie

Healthcare
Venituri pentru NeuroSense Therapeutics Ltd. (NRSN)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale NeuroSense Therapeutics Ltd., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru NeuroSense Therapeutics Ltd. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE